Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$249,297,734
+$39,326,581 QoQ
Shares Held
990,692
+2.6% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
#131
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cetera Investment Advisers holds $1,560,895,629 across 16 Drug Manufacturers - General names. ABBV ranks #3 (16.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
366,026 | $439,022,601 | |
| 2 | JNJ |
Johnson & Johnson
|
1,094,399 | $277,944,514 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
990,692 | $249,297,734 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,229,081 | $157,936,908 | |
| 5 | AMGN |
Amgen Inc
|
333,544 | $120,782,953 | |
| 6 | PFE |
Pfizer Inc
|
3,183,708 | $76,663,688 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
413,202 | $52,203,940 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
883,910 | $50,930,894 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $249,297,734 | 990,692 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $209,971,153 | 965,429 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $216,967,706 | 949,572 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $214,255,539 | 925,350 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $126,464,947 | 681,311 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $136,717,038 | 652,525 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $110,827,758 | 623,679 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $121,139,169 | 613,425 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $104,665,448 | 610,223 | Shares | Sole | 2024-08-22 | |
| 2024-03-31 | $110,757,590 | 608,224 | Shares | Sole | 2024-05-24 | |
| 2023-12-31 | $29,395,329 | 189,684 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $27,994,660 | 187,808 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $24,940,274 | 185,113 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $31,182,493 | 195,661 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $32,139,542 | 198,871 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $17,605,667 | 131,180 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $23,269,905 | 151,932 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $27,567,616 | 170,055 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $22,592,844 | 166,860 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $16,467,434 | 152,660 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $17,237,975 | 153,036 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $13,770,129 | 127,242 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $15,103,328 | 140,955 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $2,528,548 | 28,868 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,547,574 | 25,948 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,560,675 | 20,484 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||